技术资产水平、互补资产与企业绩效——基于生物制药行业上市公司的实证研究

发布时间：2018-06-10 18:16

本文选题：技术资产水平 + 互补资产　；参考：《华东经济管理》2017年06期

【摘要】：加大技术资产投入从而创造独特竞争优势已经成为高新技术企业的战略选择,然而受制于企业资源条件和能力结构的限制,过高的技术资产水平不一定能够为企业带来良好的绩效。文章在文献回顾的基础上提出研究假设,采用生物制药行业上市公司数据,对技术资产水平影响企业绩效以及互补资产的作用进行了实证研究。结果表明,技术资产水平影响企业绩效呈先上升后下降的倒"U"型关系,制造互补资产和人力互补资产正向调节技术资产水平与企业绩效关系,市场互补资产对技术资产水平与企业绩效关系的调节作用不显著。因此,高新技术企业选择合适的技术资产水平,并合理配置相关互补资产尤其是市场互补资产能使企业最大化获得绩效。
[Abstract]:Increasing investment in technical assets to create unique competitive advantages has become a strategic choice for high-tech enterprises, but limited by the resource conditions and capability structure of enterprises, Too high a level of technical assets may not necessarily bring good performance to the enterprise. On the basis of literature review, this paper makes an empirical study on the effect of the level of technical assets on corporate performance and complementary assets by using the data of listed companies in the biopharmaceutical industry. The results show that the level of technical assets affects the performance of enterprises in a reverse "U" relationship, and the manufacturing complementary assets and human complementary assets positively regulate the relationship between the level of technological assets and the performance of enterprises. The effect of market complementary assets on the relationship between the level of technical assets and enterprise performance is not significant. Therefore, high-tech enterprises can maximize their performance by choosing the appropriate level of technical assets and allocating relevant complementary assets, especially market complementary assets.
【作者单位】：常州大学商学院;南京航空航天大学经济与管理学院;
【基金】：国家社会科学基金项目(16BTQ080) 江苏省社会科学基金重点项目(15GLA001)
【分类号】：F273.1;F406.7;F426.72

【相似文献】